Shares of Galecto, Inc. (NASDAQ:GLTO – Free Report) are set to reverse split before the market opens on Friday, August 30th. The 1-25 reverse split was announced on Wednesday, August 28th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, August 29th.
Galecto Trading Down 6.6 %
NASDAQ:GLTO traded down $0.04 during mid-day trading on Wednesday, hitting $0.52. 1,402,291 shares of the company’s stock were exchanged, compared to its average volume of 193,706. The company has a 50 day simple moving average of $0.53 and a 200-day simple moving average of $0.63. Galecto has a fifty-two week low of $0.46 and a fifty-two week high of $0.94. The firm has a market capitalization of $14.10 million, a P/E ratio of -0.46 and a beta of 1.17.
Galecto (NASDAQ:GLTO – Get Free Report) last posted its earnings results on Monday, August 12th. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.32) by $0.16. As a group, analysts expect that Galecto will post -1.06 earnings per share for the current year.
Analyst Upgrades and Downgrades
Get Our Latest Research Report on GLTO
Galecto Company Profile
Galecto, Inc, a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis.
See Also
- Five stocks we like better than Galecto
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- How to Most Effectively Use the MarketBeat Earnings Screener
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- Manufacturing Stocks Investing
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Receive News & Ratings for Galecto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galecto and related companies with MarketBeat.com's FREE daily email newsletter.